R. Talac, J.A. Friedman, M.J. Moore, L. Lu, E. Jabbari, A.J. Windebank, B.L. Currier, and M.J. Yaszemski, “Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies,” Biomaterials, Vol. 25, No. 9, 2004, pp. 1505-1510.

has been cited by the following article:

• TITLE: Advances in Oligoprotection

  AUTHORS: Hong Liao, Dixit Sanjaya Mani

  KEYWORDS: Oligodendrocytes, neurovascular unit, oxidative stress, excitotoxicity; demyelinating diseases, stroke, spinal cord injury, neuropharmacology

  JOURNAL NAME: Neuroscience and Medicine, Vol.2 No.2, June 29, 2011

  ABSTRACT: Oligodendrocytes, the myelinating glial cells of the nervous system, in various disease states display great vulnerability to excitotoxic damage, oxidative stress, and inflammatory cytokines. Besides demyelinating diseases where oligoden-drocyte injury is primarily implicated, damage to them also occurs secondarily in various neuropathies. Oligoprotec-tion should, therefore, be looked into something not just as a means for protecting oligodendrocytes alone but also as a common target of protecting neurons and the neurogliovascular unit as a whole. In this review, we provide a descrip-tion on oligodendrocytes, the reasons for their vulnerability, the evolving new concepts of protecting neurovascular unit and recently neurogliovascular unit; the various diseases where oligodendrocyte injury is implicated with a brief idea on different injury mechanisms of oligodendrocytes. Finally, we present the summary of the drugs that have shown promising results in protecting oligodendrocytes or in protecting white matter as a whole in different in-vivo and in-vitro models.